Jul 2026· International Journal of Pharmaceutical Quality Assurance· Vol 16· 0 citations· 19 references
TL;DR
Prescribing practices in patients with hypertension in India were largely rational with good adherence to guidelines, however, improvement in patient education and optimization of therapy is needed.
Abstract
Background: Hypertension is a major global health concern contributing significantly to cardiovascular
morbidity and mortality. Despite the availability of effective therapies, blood pressure control remains suboptimal
in India, highlighting the need to evaluate prescribing practices.
Aim: To assess the drug utilization pattern, prescribing trends, and safety of antihypertensive medications in
patients with hypertension.
Methodology: A prospective observational study was conducted over 8 months in Department of Pharmacology,
Shree Narayan Medical institute and Hospital, Saharsa, Bihar, India, including 90 hypertensive patients. Data
were collected using structured forms and analyzed using WHO drug utilization indicators, ATC/DDD
methodology, and DU 90% analysis. Adverse drug reactions (ADRs) were monitored at 2nd and 8th weeks.
Results: The mean age was 64.2±11.35 years, with slight male predominance. Polypharmacy was observed (5.2
drugs/encounter). Most drugs were prescribed from the essential drug list (91%) and by generic name (88.5%).
Amlodipine (68.89%) and telmisartan (38.89%) were the most commonly used drugs. Amlodipine contributed the
highest DDD (46%). ADRs were few, mostly mild, and decreased over time, with no severe reactions reported.
Conclusion: Prescribing practices were largely rational with good adherence to guidelines. However,
improvement in patient education and optimization of therapy is needed.
Evaluating rational use of antihypertensive drugs according to the World Health Organization (WHO) criteria and joint national committee (JNC) 8 guidelines found no precautions and contraindications were found for any of the prescribed drug.
S. Majagi, D. Manohar, Jagadeesh Gaddeppanavar· International Journal of Bas...· 0 citations
The observed comorbidities and polypharmacy highlight the need for regular prescription review, pharmacist involvement, patient counselling, and individualized treatment to promote safe and rational antidiabetic drug use.
P. R, Santhanakumar M, D. S et al.· International journal of all...· 0 citations
No significant relationship was identified between polypharmacy and blood pressure target achievement among hypertensive patients, and regular evaluation of polypharmacy remains essential to minimize drug interactions and optimize therapeutic outcomes in hypertensive patients.
The findings revealed that over a half of the participants had antihypertensive related DTPs, and the most common DTP was dosage too low indicating a need for dosage management.
Ampereza Christine, Mohammed H. Alnazeer, Safa A. Abdalla et al.· Scientific Reports· 0 citations
Hypertension was the most frequent cardiovascular illness among geriatric people and moderate generic prescribing and compliance with NLEM suggest the necessity of regular prescription audits for promoting rational drug use.
Janvi A. Gandani, S. Misra, A. Kejriwal· International Journal of Bas...· 0 citations
NSAIDs remain the primary treatment, but high polypharmacy and poor adherence to rational prescribing indicators emphasize the need for guideline-based prescribing to improve patient outcomes.
Panchal V. Jagdishbhai, Rana K. Jagdishbhai, Patel U. Pravinbhai et al.· International Journal of Res...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.